The purpose of this study is to determine if the investigational drug bis-POM PMEA is safe to give to people infected with HIV who have a CD4+ cell counts. This study is to also find out if bis-POM PMEA helps slow the growth of HIV and if bis-POM PMEA helps those infected live longer. The study will also look to determine if those not infected with CMV keep from developing CMV and to find out if a special test that looks at how much CMV is in the blood helps to predict which people with CMV may develop CMV disease.
Showing the most recent 10 out of 211 publications